miR-137 Is Frequently Down-Regulated in Gastric Cancer and Is a Negative Regulator of Cdc42Qingjiang Chen, Xinguang Cao, Xiaobing Chen et al.|Digestive Diseases and Sciences|2011Cited by 140
A B7H3-targeting antibody–drug conjugate in advanced solid tumors: a phase 1/1b trialYuxiang Ma, Hongyun Zhao, Siqing Fu et al.|Nature Medicine|2025Cited by 76
Oxaliplatin-induced upregulation of exosomal miR-424-3p derived from human bone marrow mesenchymal stem cells attenuates progression of gastric cancer cellsSuxia Luo|Scientific Reports|2024Cited by 7
Efficacy of HX008 in high microsatellite instability/mismatch repair–defificient (MSI-H/dMMR) solid tumors: Results from a multicenter phase II open-label study.Jing Huang, Shengmian Li, Yan Song et al.|Journal of Clinical Oncology|2021Cited by 5